PEBP1 and breast carcinoma: In breast cancer, miR-4443 inhibits the expression of TIMP metallopeptidase inhibitor 2 (TIMP2) [20] and phosphatidylethanolamine binding protein 1 (PEBP1) [6], thereby promoting the metastasis and invasion of breast cancer.